Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind,...

MLA

Meyer, Sascha, et al. “Early Postnatal High-Dose Fat-Soluble Enteral Vitamin A Supplementation for Moderate or Severe Bronchopulmonary Dysplasia or Death in Extremely Low Birthweight Infants (NeoVitaA): A Multicentre, Randomised, Parallel-Group, Double-Blind,..” Lancet Respiratory Medicine, vol. 12, no. 7, July 2024, pp. 544–55. EBSCOhost, https://doi.org/10.1016/S2213-2600(24)00073-0.

APA

Meyer, S., Bay, J., Franz, A. R., Ehrhardt, H., Klein, L., Petzinger, J., Binder, C., Kirschenhofer, S., Stein, A., Hüning, B., Heep, A., Cloppenburg, E., Muyimbwa, J., Ott, T., Sandkötter, J., Teig, N., Wiegand, S., Schroth, M., Kick, A., & Wurm, D. (2024). Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind,.. Lancet Respiratory Medicine, 12(7), 544–555. https://doi.org/10.1016/S2213-2600(24)00073-0

Chicago

Meyer, Sascha, Johannes Bay, Axel R Franz, Harald Ehrhardt, Lars Klein, Jutta Petzinger, Christoph Binder, et al. 2024. “Early Postnatal High-Dose Fat-Soluble Enteral Vitamin A Supplementation for Moderate or Severe Bronchopulmonary Dysplasia or Death in Extremely Low Birthweight Infants (NeoVitaA): A Multicentre, Randomised, Parallel-Group, Double-Blind,..” Lancet Respiratory Medicine 12 (7): 544–55. doi:10.1016/S2213-2600(24)00073-0.